Home- Research
- Conferences
- Workshops & Training
- Program
- Overview
- *Innovation Cafe
- Drug Safety
- Counterfeit Drugs
- Valuation & Auditing
- Drug Discovery Innovation
- Drug Development
- Complex Systems & Org. Development
- Semantic Web
- R&D Knowledge Management
- Abstracts
- Speakers
- Allemand, P
- Barrett, J
- Gardner, S
- Gates, P
- Gibbs, A
- Hardy, B
- Henrick, K
- Jautelat, R
- Jordis, U
- Kanagy, J
- Liebman, M
- Montano, B
- Newman, V
- Polsky-Newman, R
- Scoffin, R
- Sharp, M
- Spitzner, J
- Starry, S
- Weintraub, H
- Wikel, J
- Molecular Medicine
- Nanobiotech
- Personalised Medicine
- Exhibition
- Registration
- About
- Overview
- Contact
- Support
- Schedule
|
|
|
|
|
|
|
|
|
|
|
| Steve Gardner, Ph.D., Chief Technology Officer, BioWisdom Ltd |
|
Steve Gardner leads the Technical Team at BioWisdom, which is responsible for the development of leading Ontology curation, management and delivery technologies. Steve has 18 years experience in building innovative informatics technologies, products and companies in the life science domain.
Prior to joining BioWisdom, Steve was European Managing Director and CTO of Viaken Systems, working on novel discovery applications integrating textual and structured data and building systems for the automated construction of ontologies. Prior to this he was founder and CEO of Synomics Ltd, an advanced data integration business that pioneered federated data management systems for life science research. Steve spent time inside the pharmaceutical industry as Worldwide Director of Research Informatics for Astra AB, with broad responsibility for the management and delivery of all Astra's R&D information to 8 product companies and 3,500 researchers. Steve was also Senior Product Manager at Oxford Molecular responsible for all bioinformatics and modelling products.
Steve has consulted widely and has designed and deployed enterprise informatics applications in a number of major pharmaceutical and biotechnology companies. He has published many articles and papers and is inventor of a number of patents in the area of knowledge engineering, informatics and ontology.
|
|
Ontologies: Real Applications in Pharma
Steve Gardner, Ph.D., Chief Technology Officer, BioWisdom Ltd
Ontologies have been touted as the great new hope for integrating knowledge across complex processes such as drug discovery and development. The test of whether this is hype or reality is how they enable real-world applications that generate true business value. The first generation of ontologies are beginning to demonstrate just such value in a range of applications from drug safety, biomarker discovery, market differentiation and in-licensing. This talk will describe and demonstrate ontology-enhanced applications in a number of these areas.
|
|
|
|
|
|
|
|
|
